Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02830815
Other study ID # 2015-8186
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 2016
Est. completion date November 27, 2018

Study information

Verified date June 2021
Source Children's Hospital Medical Center, Cincinnati
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This will be a prospective, blinded, cross-over study to compare the effects of two anesthetic techniques on the interpretability of auditory brainstem response testing in children.


Description:

The proposed study will be a single-center, prospective, crossover-controlled study of the two anesthetic techniques (propofol and sevoflurane). The investigators plan to enroll 80 patients who receive general anesthesia at Cincinnati Children's Hospital Medical Center Department of Radiology for ABR testing. A sample size recalculation will be performed during the study to determine the exact number of subjects necessary for sufficient power. As per standard anesthesia practice for this test in radiology department, all subjects will serve as their own control, receiving both anesthetic techniques within the same ABR testing session. The audiologist will employ broadband click stimulus testing after induction with Sevoflurane, after which the patient will be switched over to a propofol infusion and the sevoflurane stopped. After the completion of the remainder of the ABR (tone-burst testing), the audiologist will repeat the broadband click testing (now while under propofol anesthesia), and the results will be recorded. At this point, results will be de-identified, with the exception of which ear was tested and the intensity level, and these results will be reviewed by a panel of 5 audiologists. These audiologists will be blinded to the anesthetic technique and patient information. They will provide a judgment at each intensity level, for each ear whether or not a response is present (in a Yes/No format). A study coordinator blinded to the anesthetic technique will record the outcome data. The anesthesia providers and nursing team will not be blinded.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date November 27, 2018
Est. primary completion date November 27, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - 0 - 18 years old - ASA status I, II, or III - Scheduled for ABR with general anesthesia Exclusion Criteria: - Contraindication to sevoflurane or propofol - ASA >3

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital Medical Center, Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Qualitative interpretability of ABR testing in the same patient undergoing two anesthetic techniques This will be measured by a blinded panel of audiologist review the two ABR click test results and provide judgment at each intensity level, for each ear and whether or not a response is present. Participants will be followed for the duration of the ABR test approximately 60 - 90 minutes
Secondary Amplitude of Wave V of the ABR after broadband click stimulus Participants will be followed for the duration of the ABR test approximately 60 - 90 minutes
Secondary Latency of Wave V of the ABR after broadband click stimulus Participants will be followed for the duration of the ABR test approximately 60 - 90 minutes
See also
  Status Clinical Trial Phase
Completed NCT03530371 - Intranasal Dexmedetomidine for Sedated Hearing Testing Phase 3